|
Press Releases |
|
|
|
Friday, March 29, 2024 |
|
乐普生物2023年收入快速增长,亏损大幅收窄,ADC进入收获期 |
more info >> |
|
樂普生物2023年收入快速增長,虧損大幅收窄,ADC進入收穫期 |
more info >> |
|
Friday, August 25, 2023 |
|
乐普生物公布2023年中期业绩 |
聚焦于肿瘤治疗领域的创新型生物制药公司──乐普生物科技股份有限公司(「乐普生物」或「公司」,股份代号:2157.HK),于今日公布2023年中期业绩。 more info >> |
|
樂普生物公佈2023年中期業績 |
聚焦於腫瘤治療領域的創新型生物製藥公司──樂普生物科技股份有限公司(「樂普生物」或「公司」,股份代號:2157.HK),於今日公佈2023年中期業績。 more info >> |
|
Friday, March 17, 2023 |
|
乐普生物公布2022年度业绩 |
聚焦于肿瘤治疗领域的创新型生物制药公司──乐普生物科技股份有限公司(「乐普生物」或「公司」,股份代号:2157.HK),于今日公布2022年度业绩。 more info >> |
|
樂普生物公佈2022年度業績 |
聚焦於腫瘤治療領域的創新型生物製藥公司──樂普生物科技股份有限公司(「樂普生物」或「公司」,股份代號:2157.HK),於今日公佈2022年度業績。 more info >> |
|
Thursday, February 23, 2023 |
|
乐普生物和康诺亚共同宣布与阿斯利康就CMG901达成全球独家授权协议 |
乐普生物科技股份有限公司 (HK:02157)和康诺亚生物医药科技有限公司(HK:02162)今日共同宣布与阿斯利康(AstraZeneca,LSE/STO/纳斯达克:AZN)就潜在世界首创Claudin 18.2抗体偶联药物CMG901达成全球独家授权协议。 more info >> |
|
樂普生物和康諾亞共同宣佈與阿斯利康就CMG901達成全球獨家授權協定 |
樂普生物科技股份有限公司 (HK:02157)和康諾亞生物醫藥科技有限公司(HK:02162)今日共同宣佈與阿斯利康(AstraZeneca,LSE/STO/納斯達克:AZN)就潛在世界首創Claudin 18.2抗體偶聯藥物CMG901達成全球獨家授權協定。 more info >> |
|
Lepu Biopharma and Keymed Jointly Announces Global Exclusive Licence Agreement with AstraZeneca for CMG901 |
On 23 February, 2023, Lepu Biopharma Co., Ltd. (Stock Code: 02157.HK) and Keymed Biosciences Inc., ("Keymed") (Stock Code: 02162 HK) today jointly announces a global exclusive licence agreement with AstraZeneca (LSE/STO/Nasdaq: AZN) for CMG901, a potential first-in-class Claudin 18.2 antibody drug conjugate (ADC). more info >> |
|
Thursday, September 29, 2022 |
|
乐普生物PD-1单抗普佑恒(TM)获批新适应症,MRG003获CDE纳入突破性治疗药物名单 |
乐普生物科技股份有限公司 (「乐普生物」或「公司」,股份代号:2157.HK) 宣布,公司旗下首款创新型生物药抗PD-1抗体——普佑恒™(通用名:普特利单抗注射液)已获得国家药品监督管理局(NMPA)批准上市销售。 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Asia Summit on Global Health and Hong Kong International Medical and Healthcare Fair conclude successfully
May 19, 2024 15:06 HKT/SGT
|
|
|
華住公佈2024年第一季度財報 收入增長17.8%优于预期
May 17, 2024 22:39 HKT/SGT
|
|
|
H World Group Limited Reports Q1 2024 Financial Results with 17.8% Revenue Growth, Surpassing Expectation
May 17, 2024 22:29 HKT/SGT
|
|
|
Top executives from SDAIA, Saudi Aramco, Almarai, Saudi Pro League & many others coming to speak at Smart Data & AI Summit
May 17, 2024 20:09 HKT/SGT
|
|
|
卓悦集团附属公司与“湖南广电芒果超媒”旗下“快乐购”签署战略合作备忘录
May 17, 2024 20:00 HKT/SGT
|
|
|
卓悅集團附屬公司與「湖南廣電芒果超媒」旗下「快樂購」簽署戰略合作備忘錄
May 17, 2024 19:43 HKT/SGT
|
|
|
Raytech Holding: Making Nasdaq Debut as It Pioneers Personal Care Electrical Appliances in a Booming Market
May 17, 2024 18:00 HKT/SGT
|
|
|
中信国际电讯CPC守正创新 AI创新方案喜迎两大奖
May 17, 2024 17:04 HKT/SGT
|
|
|
中信國際電訊CPC守正創新 AI創新方案喜迎兩大獎
May 17, 2024 16:55 HKT/SGT
|
|
|
CITIC Telecom CPC's Innovation Excellence Honored with 2 Innovation Awards
May 17, 2024 16:37 HKT/SGT
|
|
|
London Climate Technology Show 2024 Returns For Third Edition at ExCeL London
May 17, 2024 15:48 HKT/SGT
|
|
|
Sri Trang (SET: STA) announces delivery of EUDR rubber to customers
May 17, 2024 15:00 HKT/SGT
|
|
|
Sri Trang (SET: STA) announces delivery of EUDR rubber to customers
May 17, 2024 15:00 HKT/SGT
|
|
|
富士通、論理推論を可能とする大規模言語モデルの研究開発が「GENIAC」に採択
May 17, 2024 14:00: JST
|
|
|
Fujitsu chosen for GENIAC project, starts development of large language models for logical reasoning
May 17, 2024 14:03 JST
|
|
|
|
More News >> |
|
|
|
|
|